Download presentation
Presentation is loading. Please wait.
Published byHillary Stephany Melton Modified over 9 years ago
1
Dr Aslesh OP MBBS, MD Assistant professor, community medicine Pariyaram Medical College
2
History Burden Agent vector Epidemiology Clinical features control
4
Ancient references China, Assyria, India 500 BC Hippocrates gives first clinical description
5
Ancient references China, Assyria, India 500 BC Hippocrates gives first clinical description Historical Impacts 413 BC Fall of Greek empire 323 BC Alexander the Great died of malaria The Roman Empire: Malaria is generally considered to have played a role in the decline of Rome, a city located in marshland, where malaria is transmitted In world war 2, more people died due to malaria than in war
7
Globally 150 to 300 million cases annually 81% in African region 13% South east Asian region 5% eastern Mediterranean
8
In India 27% of the population live in malaria high transmission area 58% in low transmission area
10
Plasmodium –4 species P falciparum P vivax P ovale P malaria
13
Only human reservoir
14
Age Sex Genetic- sickle cell anemia, duffy negative blood type Low socio economic status Poor housing standards Migration Occupation- agriculture
15
Season-Rainy season Temperature – 16-30 degree High humidity- above 60% Altitude- less than 2500 metes
16
Length of time between infective mosquito bite and first appearance of fever P Falciparum malaria- 12 days P Vivax -14 days P malaria- 28 days P ovale -17 days
17
Typical fever- 3 stages Cold stage Chills and rigor Last for 1/4 th to 1 hour Hot stage Hot and dry Last for 2-6 hour Sweating stage Fever comes down with profuse sweating
18
Cerebral malaria Renal failure Liver damage Dehydration Anemia
19
Microscopy-Blood smear examination for parasite Serological test- fluorescent antibody test Rapid diagnostic test
20
For falciparum Artisunate combination therapy For vivax Chloroquine along with primaquine
21
Infected People Mosquitoes Uninfected People contact Habitat Climate Food Source of Plasmodium Source of New Hosts Habitat Behavior
22
Infected People Mosquitoes Uninfected People contact Habitat Climate Food Source of Plasmodium Source of New Hosts Habitat Behavior
23
Destroy habitat Insecticides Biological control
25
Rapid Reproduction Natural selection
29
Drug treatment Transgenic mosquitoes
30
Drug treatment Transgenic mosquitoes Why don’t these work?
31
Drug treatment Transgenic mosquitoes Why don’t these work? Availability of drugs Money Medical staff Recrudescense Drug resistance Reservoir hosts? Transgenic mosquitoes not a reality Expensive
32
Vaccines Prophylactic drugs
33
Vaccines Prophylactic drugs Why don’t these work?
34
Vaccines Prophylactic drugs Why don’t these work? Vaccines unsuccessful Prophylactic drugs expensive Prophylactic drugs unpleasant
35
Insecticides Mosquito nets Long clothing Behavior Avoid mosquito habitat Screens on houses
36
Insecticides Mosquito nets Long clothing Behavior Avoid mosquito habitat Screens on houses Why don’t these work?
37
Insecticides Mosquito nets Long clothing Behavior Avoid mosquito habitat Screens on houses Why don’t these work? Money Availability of materials Human behavior difficult to change
38
Dengue Chikenguniya Filariasis Japanese encephalitis
39
Dengue fever Chikunguniya Yellow fever in African countries
41
Culex mosquito Filarial scrotum Filarial leg 120 millions in 73 countries SEAR countries 31 millions clinical cases, 60 millions mf carriers India 45 prevalence millions, incidence 6 millions per year
42
Observe dry day once a week
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.